Description
Bravecto for Cats is a safe and effective topical flea and tick treatment that provides up to 12 weeks of protection.
It is indicated for the treatment and prevention of flea infestations (Ctenocephalides felis) and the treatment and control of black-legged tick (Ixodes scapularis) infestations for 12 weeks in cats and kittens 6 months of age and older, and weighing 2.6 lbs or greater.
This easy-to-apply formula also treats and controls Dermacentor variabilis (American dog tick) infestations for 8 weeks.
With one application, Bravecto for Cats will protect your cat against fleas for three times as long as most leading flea and tick preventatives.
This means less of a chance of missing a dose, making it easier to keep your cat protected year-round. One dose effectively breaks the 3-month flea life cycle, from egg to adulthood.
For:
Cats and Kittens (2.6+ lbs, 6 months of age or older)
- Effective prevention and treatment for fleas (Ctenocephalides felis) and black-legged ticks (Ixodes scapularis) for up to 12 weeks
- Treats and controls Dermacentor variabilis (American dog tick) infestations for 8 weeks
- Kills 100% of fleas within 8 hours of application
- Effectively breaks the 3-month flea life cycle
- Close to a full year of protection with only 4 doses. No more monthly dosing!
- Fewer doses mean fewer chances to miss a dose decreasing the likelihood of having gaps in protection
- Easy to apply
After applying Bravecto for Cats, the medication quickly reaches tissue fluids under your cat's skin. When fleas and ticks feed on your cat, they ingest Bravecto for Cats and die. Bravecto for Cats kills fleas, prevents flea infestations and kills black-legged ticks for 12 weeks. Bravecto for Cats also treats and controls American dog ticks for 8 weeks.
Not for human use. Keep this and all drugs out of the reach of children. Do not contact or allow children to contact the application site until dry. Keep the product in the original packaging until use in order to prevent children from getting direct access to the product. Do not eat, drink or smoke while handling the product. Avoid contact with skin and eyes. If contact with eyes occurs, then flush eyes slowly and gently with water. Wash hands and contacted skin thoroughly with soap and water immediately after use of the product. The product is highly flammable. Keep away from heat, sparks, open flame or other sources of ignition. For topical use only. Avoid oral ingestion. Use with caution in cats with a history of neurologic abnormalities. Neurologic abnormalities have been reported in cats receiving Bravecto, even in cats without a history of neurologic abnormalities. Bravecto has not been shown to be effective for 12-weeks duration in kittens less than 6 months of age. Bravecto is not effective against Dermacentor variabilis ticks beyond 8 weeks after dosing. The safety of Bravecto has not been established in breeding, pregnant and lactating cats.
Bravecto for Cats
Fluralaner
Bravecto for Cats kills adult fleas and is indicated for the treatment and prevention of flea infestations of cat fleas (Ctenocephalides felis), and the treatment and control of tick infestations of black-legged ticks (Ixodes scapularis) for 12 weeks in cats and kittens 6 months of age and older, and weighing 2.6 pounds or greater. Bravecto for Cats is also indicated for the treatment and control of American dog tick (Dermacentor variabilis) infestations for 8 weeks in cats and kittens 6 months of age and older and weighing 2.6 pounds or more.
Bravecto for Cats should be administered topically as a single dose every 12 weeks according to the dosage schedule (How to Use tab) to provide a minimum dose of 18.2 mg/lb (40 mg/kg) body weight. Treatment with Bravecto for Cats may begin at any time of the year and can continue year round without interruption.
Bravecto for Cats is available in three strengths for use in cats (112.5 mg, 250 mg, and 500 mg fluralaner per tube). Each tube is packaged individually in a pouch.
Bravecto for Cats is for topical use only. Avoid oral ingestion. Use with caution in cats with a history of neurologic abnormalities. Neurologic abnormalities have been reported in cats receiving Bravecto, even in cats without a history of neurologic abnormalities. Bravecto for Cats has not been shown to be effective for 12-weeks duration in kittens less than 6 months of age. Bravecto is not effective against Dermacentor variabilis ticks beyond 8 weeks after dosing. The safety of Bravecto has not been established in breeding, pregnant and lactating cats.
In a well-controlled U.S. field study, there were no serious adverse reactions. Possible side effects may include vomiting, pruritus, diarrhea, alopecia, decreased appetite, lethargy, or scabs/ulcerated lesions following application.
There are no known contraindications for the use of the product.
Do not store above 86°F (30°C). Store in the original package in order to protect from moisture. The pouch should only be opened immediately prior to use.
